Asia-Pacific’s medical devices industry saw a drop of 25.58% in deal activity during April 2022, when compared with the last 12-month average, led by Winner Medical Group’s $114.35m acquisition of 55% stake in Zhejiang Longtai Medical Technology, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 32 medical devices industry deals worth $382m were announced for the region in April 2022, against the 12-month average of 43 deals.

Of all the deal types, venture financing saw most activity in April 2022 with 28 transactions, representing an 87.5% share for the region.

In second place was M&A with four deals capturing a 12.5% share of the overall deal activity for the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In terms of value of deals, M&A was the leading category in Asia-Pacific’s medical devices industry with $193.19m, followed by venture financing deals totalled $188.77m.

Asia-Pacific medical devices industry deals in April 2022: Top deals

The top five medical devices deals accounted for 76.02% of the overall value during April 2022.

The combined value of the top five medical devices deals stood at $290.35m, against the overall value of $382m recorded for the month.

The top five medical devices industry deals of April 2022 tracked by GlobalData were:

1) Winner Medical Group $114.35m acquisition deal for 55% stake in Zhejiang Longtai Medical Technology

2) The $74.59m acquisition of ResApp Health by Pfizer Australia Holdings

3) Globis Capital Partners &,Incubate Fund,SoftBank Vision Fund 2 and World Innovation Lab (WiL fund) $70m venture financing deal with AI Medical Service

4) The $15.71m venture financing of Shanghai Yipu Biotechnology by Industrial Capital

5) Boyuan Capital,Guotai Junan Innovation Investment and Yinshengtai Capital $15.7m venture financing deal with Shanghai Ruijing Biotechnology